The Impact of the BCR Phenotype of Large B-cell Lymphoma on Ibrutinib Sensitivity

PYRY KOTKARANTA, MIKKO CHAN, HANNA-RIIKKA TEPPO, HANNE KUITUNEN, TAINA TURPEENNIEMI-HUJANEN, OUTI KUITTINEN, MILLA E.L. KUUSISTO

Open source

DOI: 10.21873/anticanres.18230
Published: 2026-06-29
Container: Anticancer Research
Publisher: International Institute of Anticancer Research
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.21873/anticanres.18230,
  title = {The Impact of the BCR Phenotype of Large B-cell Lymphoma on Ibrutinib Sensitivity},
  author = {PYRY KOTKARANTA and MIKKO CHAN and HANNA-RIIKKA TEPPO and HANNE KUITUNEN and TAINA TURPEENNIEMI-HUJANEN and OUTI KUITTINEN and MILLA E.L. KUUSISTO},
  year = {2026},
  journal = {Anticancer Research},
  doi = {10.21873/anticanres.18230},
  url = {https://doi.org/10.21873/anticanres.18230}
}

RIS

TY  - JOUR
TI  - The Impact of the BCR Phenotype of Large B-cell Lymphoma on Ibrutinib Sensitivity
AU  - PYRY KOTKARANTA
AU  - MIKKO CHAN
AU  - HANNA-RIIKKA TEPPO
AU  - HANNE KUITUNEN
AU  - TAINA TURPEENNIEMI-HUJANEN
AU  - OUTI KUITTINEN
AU  - MILLA E.L. KUUSISTO
PY  - 2026
JO  - Anticancer Research
DO  - 10.21873/anticanres.18230
UR  - https://doi.org/10.21873/anticanres.18230
ER  -

APA

KOTKARANTA, P., CHAN, M., TEPPO, H., KUITUNEN, H., TURPEENNIEMI-HUJANEN, T., KUITTINEN, O., & KUUSISTO, M. E. (2026). The Impact of the BCR Phenotype of Large B-cell Lymphoma on Ibrutinib Sensitivity. Anticancer Research. https://doi.org/10.21873/anticanres.18230

Source records

crossref · retrieved 2026-09-26T15:33:52.551Z